The International (Xiong 'an) Robot Industry Alliance was formally established. On December 12th, it was learned from the 2024 xiong'an new area Intelligent Robot Industry Development Conference held in xiong'an new area, Hebei Province that the International (Xiong 'an) Robot Industry Alliance and Xiong 'an Robot Innovation and Technology Research Institute were formally established. "As an important representative of the future industry, the intelligent robot industry is in a critical period of rapid development. The establishment of the International (Xiong 'an) Robot Industry Alliance will strongly promote the development of Xiong 'an robot industry, and the establishment of Xiong 'an Robot Innovation Technology Research Institute will provide strong technical support for the sustainable development of intelligent robot industry, marking a solid step in technology research and development and innovation of xiong'an new area robot industry. " Zhang Qin, former vice chairman of China Association for Science and Technology, said. (xinhuanet)Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.InBev Cloud released a number of intelligent computing products. On December 13th, InBev Mathematics Department officially released a brand-new series of intelligent computing products and services, covering the construction and operation of intelligent computing centers, GPU container services, advanced computing laboratories and industrial incubators, and put forward the innovative index of "effective computing cost per unit" for the first time in the industry, so as to promote the intelligent computing industry to a high-efficiency and diversified development paradigm.
Huatong Co., Ltd.: The sales revenue of live pigs in November was 410 million yuan. Huatong Co., Ltd. announced that in November 2024, the company sold 201,000 pigs, including 10,600 piglets. The sales revenue of live pigs reached 410 million yuan, an increase of 20.56% from the previous month. The average selling price of commercial pigs was 16.5 yuan/kg, down 4.07% from October. In addition, the number of chickens sold in November was 1,205,900, a decrease of 47.69% from the previous month and a year-on-year increase of 19.79%. Chicken sales revenue was 20,213,700 yuan, an increase of 23.65% from the previous month. Sales data are unaudited for investors' reference.Gao Xiuying, the former deputy general manager of CITIC Daika Co., Ltd., was "double-opened". After investigation, Gao Xiuying, as a leading cadre of party member, a state-owned enterprise, abandoned his initial mission and deliberately opposed organizational review, taking the lead in breaking the discipline and breaking the law, seriously polluting the political ecology of his unit; Ignoring the spirit of the eight central regulations, illegally accepting gifts, banquets and travel arrangements; Violation of organizational principles, failure to report personal matters truthfully, running away from official positions, and making profits for relatives and friends in employee recruitment and job transfer; There is no bottom line for honesty, illegally holding shares of non-listed companies, and wantonly engaging in illegal business operations abroad to obtain huge profits; Failing to report and submit working materials to the superior unit as required; Moral corruption, violation of life discipline. Rely on enterprises to eat enterprises, harm the public and enrich the private interests, use their powers to ask for property from subordinates, illegally operate the same business of the enterprises they serve, and seek huge illegal interests.Indian market regulator: issue a draft notice to solicit opinions from retail investors on algorithmic trading. Algorithm trading should be provided by securities brokers and approved by the stock exchange.
Alipay sells cryptocurrency funds? Originally an indirect investment in a product of Huabao Fund, the subscription has been suspended. Recently, some netizens found that Huabao Fund promoted a fund product issued by Huabao Fund in Alipay-QDII-FOF-LOF C (hereinafter referred to as "Huabao Overseas Technology C"), promoting "riding the wind to encrypt the rising market of currency" and "the representative of subversive innovation technology: cryptocurrency". According to the report of Warburg Overseas Technology C in the third quarter of this year, among the top ten funds with the highest fair value at the end of the reporting period, five were only index funds managed by Ark Investment Management under Cathy Wood, the "Mujie", accounting for 73.12% of the total. Looking through the archives of ARK Management Fund, the reporter found that ARK Innvonation ETF (hereinafter referred to as "ARKK"), the largest heavyweight of Huabao Overseas Technology C, was invested in Coinbase, a cryptocurrency exchange. ARK Next Generation Internet ETF (hereinafter referred to as "ARKW"), the second largest warehouse, invests in GBTC(Grayscale Bitcoin Trust) or investment tools such as Bitcoin, Ethereum and other cryptocurrency ETFs. ARKW also suggests the risks related to the indirect investment of funds in cryptocurrencies. In addition, Coinbase ranks third among ARKW's heavy stocks. The reporter logged on to several consignment platforms such as Ant Fortune, Licaitong, Tiantian Fund, China Merchants Bank, Snowball Fund and found that the product was sold on the above platforms, but from December 11th, the large subscription of Class A shares and Class C shares was suspended, and the daily limit for each person was 1000 yuan RMB. However, on December 13th, Huabao Overseas Science and Technology Stock Securities Investment Fund announced that it would suspend subscription and regular fixed investment business. (21 Finance)Alipay sells cryptocurrency funds? Originally an indirect investment in a product of Huabao Fund, the subscription has been suspended. Recently, some netizens found that Huabao Fund promoted a fund product issued by Huabao Fund in Alipay-QDII-FOF-LOF C (hereinafter referred to as "Huabao Overseas Technology C"), promoting "riding the wind to encrypt the rising market of currency" and "the representative of subversive innovation technology: cryptocurrency". According to the report of Warburg Overseas Technology C in the third quarter of this year, among the top ten funds with the highest fair value at the end of the reporting period, five were only index funds managed by Ark Investment Management under Cathy Wood, the "Mujie", accounting for 73.12% of the total. Looking through the archives of ARK Management Fund, the reporter found that ARK Innvonation ETF (hereinafter referred to as "ARKK"), the largest heavyweight of Huabao Overseas Technology C, was invested in Coinbase, a cryptocurrency exchange. ARK Next Generation Internet ETF (hereinafter referred to as "ARKW"), the second largest warehouse, invests in GBTC(Grayscale Bitcoin Trust) or investment tools such as Bitcoin, Ethereum and other cryptocurrency ETFs. ARKW also suggests the risks related to the indirect investment of funds in cryptocurrencies. In addition, Coinbase ranks third among ARKW's heavy stocks. The reporter logged on to several consignment platforms such as Ant Fortune, Licaitong, Tiantian Fund, China Merchants Bank, Snowball Fund and found that the product was sold on the above platforms, but from December 11th, the large subscription of Class A shares and Class C shares was suspended, and the daily limit for each person was 1000 yuan RMB. However, on December 13th, Huabao Overseas Science and Technology Stock Securities Investment Fund announced that it would suspend subscription and regular fixed investment business. (21 Finance)Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13